- Home
- GHRS vs HQH Comparison
GHRS vs HQH Comparison
Compare GHRS & HQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | HQH |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 892.0M | 1.0B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GHRS | HQH |
|---|---|---|
| Price | $13.05 | $18.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $30.11 | N/A |
| AVG Volume (30 Days) | ★ 247.9K | 183.8K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.09 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.24 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.72 | $14.31 |
| 52 Week High | $20.50 | $17.94 |
Technical Indicators
Market Signals| Indicator | GHRS | HQH |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 51.44 |
| Support Level | $13.94 | $18.81 |
| Resistance Level | $15.00 | $19.10 |
| Average True Range (ATR) | 0.84 | 0.34 |
| MACD | -0.15 | -0.02 |
| Stochastic Oscillator | 3.99 | 37.84 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About HQH abrdn Healthcare Investors Shares of Beneficial Interest
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.